HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ulrich Hutzschenreuter Selected Research
Ulrich Hutzschenreuter Research Topics
Disease
2
Neoplasms (Cancer)
11/2021 - 01/2015
2
Breast Neoplasms (Breast Cancer)
11/2021 - 10/2017
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021
1
Lung Neoplasms (Lung Cancer)
01/2019
1
Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2017
1
Ovarian Neoplasms (Ovarian Cancer)
12/2015
1
Carcinoma (Carcinomatosis)
12/2015
1
Colorectal Neoplasms (Colorectal Cancer)
01/2015
Drug/Important Bio-Agent (IBA)
1
pegfilgrastim (Neulasta)
FDA Link
11/2021
1
Anthracyclines
IBA
11/2021
1
taxane
IBA
11/2021
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2021
1
Sorafenib (BAY 43-9006)
FDA Link
06/2017
1
Sunitinib (Sutent)
FDA Link
06/2017
1
Bevacizumab (Avastin)
FDA Link
06/2017
1
Interferons
IBA
06/2017
1
temsirolimus
FDA Link
06/2017
1
Alkylating Agents
IBA
12/2015
1
treosulfan
IBA
12/2015
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2015
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2015
Therapy/Procedure
1
Therapeutics
01/2019
1
Aftercare (After-Treatment)
10/2017
1
Adjuvant Chemotherapy
10/2017
1
Combination Drug Therapy (Combination Chemotherapy)
01/2015
1
Drug Therapy (Chemotherapy)
01/2015